$497 Million is the total value of Two Seas Capital LP's 14 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 53.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | INDIVIOR PLCord | $315,374,087 | -3.1% | 13,670,312 | +0.0% | 63.41% | -10.8% | |
| Buy | ROIVANT SCIENCES LTD | $92,449,910 | +16.0% | 7,915,232 | +0.1% | 18.59% | +6.7% | |
| ABUS | ARBUTUS BIOPHARMA CORP | $16,810,061 | -11.7% | 8,280,818 | 0.0% | 3.38% | -18.8% | |
| IMVT | New | IMMUNOVANT INC | $16,402,358 | – | 427,256 | +100.0% | 3.30% | – |
| MMM | New | 3M CO | $12,170,600 | – | 130,000 | +100.0% | 2.45% | – |
| FB | Buy | META PLATFORMS INCcl a | $10,860,097 | +26.1% | 36,175 | +20.6% | 2.18% | +16.0% |
| New | ESPERION THERAPEUTICS INC NEnote 4.000%11/1 | $9,358,127 | – | 17,275,000 | +100.0% | 1.88% | – | |
| ESPR | Buy | ESPERION THERAPEUTICS INC NE | $7,518,727 | +83.9% | 7,672,170 | +160.8% | 1.51% | +69.1% |
| SONO | Buy | SONOS INC | $5,243,681 | +87.6% | 406,172 | +137.3% | 1.05% | +72.5% |
| OMEX | ODYSSEY MARINE EXPL INC | $5,130,809 | +3.9% | 1,371,874 | 0.0% | 1.03% | -4.4% | |
| IMVT | New | IMMUNOVANT INCcall | $3,324,574 | – | 86,600 | +100.0% | 0.67% | – |
| HTZZ | Sell | HERTZ GLOBAL HLDGS INC | $1,068,053 | -68.4% | 87,188 | -52.6% | 0.22% | -70.9% |
| ARQT | Sell | ARCUTIS BIOTHERAPEUTICS INC | $875,125 | -60.5% | 164,807 | -29.0% | 0.18% | -63.6% |
| HTZZW | HERTZ GLOBAL HLDGS INC*w exp 06/30/205 | $755,783 | -39.3% | 123,494 | 0.0% | 0.15% | -44.1% | |
| Exit | MALLINCKRODT PLC | $0 | – | -585,602 | -100.0% | -0.15% | – | |
| AMBC | Exit | AMBAC FINL GROUP INC | $0 | – | -187,568 | -100.0% | -0.58% | – |
| Exit | ROIVANT SCIENCES LTD*w exp 09/30/202 | $0 | – | -1,100,662 | -100.0% | -0.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HERTZ GLOBAL HLDGS INC | 8 | Q3 2023 | 79.6% |
| ROIVANT SCIENCES LTD | 8 | Q3 2023 | 52.9% |
| ARBUTUS BIOPHARMA CORP | 8 | Q3 2023 | 20.8% |
| ODYSSEY MARINE EXPL INC | 8 | Q3 2023 | 5.5% |
| HERTZ GLOBAL HLDGS INC | 8 | Q3 2023 | 1.0% |
| AMBAC FINL GROUP INC | 7 | Q2 2023 | 4.0% |
| SONOS INC | 7 | Q3 2023 | 5.1% |
| ROIVANT SCIENCES LTD | 7 | Q2 2023 | 1.3% |
| RENREN INC | 4 | Q3 2022 | 15.0% |
| META PLATFORMS INC | 4 | Q3 2023 | 7.9% |
View Two Seas Capital LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-03-29 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2023-11-21 |
| 13F-HR | 2023-11-14 |
| SC 13G | 2023-10-05 |
| SC 13D | 2023-10-02 |
| 13F-HR | 2023-08-14 |
View Two Seas Capital LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.